Gen QA

MEMBER LOGIN

MENU menu

Close close menu

Lymphoma Technical NGS (pilot)

BACK TO EQA DIRECTORY

Next Generation Sequencing (NGS) analysis for detection of clinically relevant structural changes, copy number changes and single nucleotide variants associated with Lymphoma. The lymphoma samples provided will be either diagnostic primary samples, or infiltrated staging samples (where primary samples are not available).

EQA INFORMATION

EQA Code
HLYT
Submission
Clinical Report
Techniques
Next Generation Sequencing (NGS)
Eligibility
All laboratories worldwide
Language
English, French, German, Italian, Polish, Portuguese, Spanish
EQA Accreditation
Pilot
EQA open

01 September 2025

Testing period
6 weeks

OTHER INFORMATION

Other related EQAs: 
For FISH testing, please enrol in the GenQA Lymphoma EQA.
For quantitative EQA for liquid biopsy lymphoma referrals please contact UK NEQAS LI.

 What are participants required to do?
  • Enrolled participants will receive details by email when an EQA is open for assessment and/or samples have been dispatched.  
  • Participants are expected to access the instructions and information for the cases/samples online and to analyse them according to their laboratory/centre protocols. 
  • Participants must submit their anonymised results by the deadline using their standard laboratory report or a proforma provided by GenQA.  The submitted results are independently assessed for the accuracy of the analytical/genotyping results, clinical interpretation of the results (if appropriate) and clerical accuracy (including report layout and content). 

What can I expect as a participant?
Every participant will receive:
  • An Individual Laboratory/Centre Report (ILR/ICR) with educational advice for each distribution of this EQA.
  • The Summary report for each distribution of this EQA which contains information regarding general findings, a summary of methodologies used, common errors, number of participants and benchmarking. 
  • Access to a live Performance Certificate summarising your performance status for all EQAs in which you are enrolled.

Please note: EQA details may be subject to change prior to EQA distribution.   

PRODUCTS

Sample type: FFPE (Formalin Fixed Paraffin Embedded sections)
Testing/analysis: Detection of recurrent abnormalities associated with lymphoma.
Conditions/Gene target(s):
  • Non-Hodgkin Lymphoma (NHL)
Number of cases: Two

LOGIN TO PURCHASE

 

ASK A QUESTION

Lymphoma Technical NGS (pilot)

Enter your details here: